Cv Sciences Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CV Sciences (OTCMKTS:CVSI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment […]

CV Sciences (OTCMKTS:CVSI – Get Rating) released its quarterly earnings results on Monday. The company reported ($0.02) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.02), MarketWatch Earnings reports. CV Sciences had a negative net margin of 77.58% and a negative return on equity of 169.87%. Shares of CVSI traded down $0.00 […]